Emergency Department and EICU, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, PR China.
Ren Fail. 2020 Nov;42(1):638-645. doi: 10.1080/0886022X.2020.1788581.
Acute kidney injury (AKI) is the most common cause of organ failure in multiple organ dysfunction syndrome (MODS) and is associated with increased mortality. This study aimed at determining the efficacy of sequential organ failure assessment (SOFA), and acute physiology and chronic health evaluation II (APACHE-II) scoring systems in assessing the prognosis of critically ill patients with AKI undergoing CRRT.
The predictive value of SOFA and APACHE-II scores for 28- and 90-d mortality in patients with AKI undergoing continuous renal replacement therapy (CRRT) were determined by multivariate analysis, sensitivity analysis, and curve-fitting analysis.
A total of 836 cases were included in this study. Multivariate Cox logistic regression analysis showed that SOFA scores were associated with 28- and 90-d mortality in patients with AKI undergoing CRRT. The adjusted HR of SOFA for28-d mortality were 1.18 (1.14, 1.21), 1.24 (1.18, 1.31), and 1.19 (1.13, 1.24) in the three models, respectively, and the adjusted HR of SOFA for 90-d mortality was 1.12 (1.09, 1.16), 1.15 (1.10, 1.19), and 1.15 (1.10, 1.19), respectively. The subgroup analysis showed that the SOFA score was associated with 28-d and 90-d mortality in patients with AKI undergoing CRRT. APACHE-II score was not associated with 28- and 90-d mortality patients with AKI undergoing CRRT. Curve fitting analysis showed that SOFA scores increased had a higher prediction accuracy for 28- and 90-d than APACHE-II.
The SOFA score showed a higher accuracy of mortality prediction in critically ill patients with AKI undergoing CRRT than the APACHE-II score.
急性肾损伤(AKI)是多器官功能障碍综合征(MODS)中最常见的器官衰竭原因,与死亡率增加有关。本研究旨在确定序贯器官衰竭评估(SOFA)和急性生理学和慢性健康评估 II(APACHE-II)评分系统在评估接受连续肾脏替代治疗(CRRT)的 AKI 危重症患者预后中的作用。
通过多变量分析、敏感性分析和曲线拟合分析,确定 SOFA 和 APACHE-II 评分对接受 CRRT 的 AKI 患者 28 天和 90 天死亡率的预测价值。
本研究共纳入 836 例患者。多变量 Cox 逻辑回归分析显示,SOFA 评分与接受 CRRT 的 AKI 患者 28 天和 90 天死亡率相关。SOFA 预测 28 天死亡率的调整后 HR 在三个模型中分别为 1.18(1.14,1.21)、1.24(1.18,1.31)和 1.19(1.13,1.24),SOFA 预测 90 天死亡率的调整后 HR 分别为 1.12(1.09,1.16)、1.15(1.10,1.19)和 1.15(1.10,1.19)。亚组分析显示,SOFA 评分与接受 CRRT 的 AKI 患者的 28 天和 90 天死亡率相关。APACHE-II 评分与接受 CRRT 的 AKI 患者的 28 天和 90 天死亡率无关。曲线拟合分析表明,SOFA 评分升高对 28 天和 90 天死亡率的预测准确性高于 APACHE-II。
SOFA 评分在预测接受 CRRT 的 AKI 危重症患者死亡率方面的准确性高于 APACHE-II 评分。